Meeting report: "Antibodies-Europe. Engineering the next generation of antibodies"

Biotechnology Journal

Volumn 3, Issue 3, 2008, Pages 298-301

  Moutel, Sandrine ^a   Perez, Franck ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; CD20 ANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; OLIGOSACCHARIDE; POLYPEPTIDE; RECOMBINANT ANTIBODY;

ANTIBODY ENGINEERING; ANTIBODY PRODUCTION; ANTIGEN BINDING; BINDING AFFINITY; CANCER THERAPY; CHO CELL; CONFERENCE PAPER; CYTOTOXICITY; DISULFIDE BOND; DRUG SYNTHESIS; EFFECTOR CELL; EUROPE; FUCOSYLATION; HUMAN; IMMUNOGENICITY; MAMMAL CELL; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RNA INTERFERENCE; SOMATIC HYPERMUTATION; TOBACCO; TWO HYBRID SYSTEM; BIOSYNTHESIS; DRUG INDUSTRY; FORECASTING; PROTEIN ENGINEERING;

ANTIBODIES, MONOCLONAL; DRUG INDUSTRY; EUROPE; FORECASTING; PROTEIN ENGINEERING;

EID: 41549127546     PISSN: 18606768     EISSN: None     Source Type: Journal    
DOI: 10.1002/biot.200800011     Document Type: Conference Paper

References (7)

1. Mondon et al., Biotechnol. J. 2007, 2, 76-82.
2. Schähs et al., Plant Biotechnol. J. 2007, 5, 657-63.
3. Van Droogenbroeck et al., Proc Natl. Acad. Sci. USA. 2007, 104, 1430-1435.
4. Cox et al., Nat. Biotechnol. 2006, 241591-241597.
5. Taylor et al., Nat. Biotechnol. 2007, 8, 887-893.
6. Sennhauser et al., PLoS Biol. 2007, 5, e7.
7. Ng et al., Nat. Rev. Drug Discov. 2006, 5, 123-132.